Inovio Pharmaceuticals, Inc

(NASDAQ:INO)

Latest On Inovio Pharmaceuticals, Inc (INO):

Date/Time Type Description Signal Details
2023-05-24 03:50 ESTNewsInovio wins orphan drug status for HPV-related candidate in EuropeN/A
2023-05-18 07:17 ESTNewsInovio Pharmaceuticals, Inc. (INO) 2023 RBC Capital Markets Global Healthcare Conference (Transcript)N/A
2023-05-17 18:36 ESTNewsInovio Corporate PresentationN/A
2023-05-11 06:41 ESTNewsInovio Pharmaceuticals, Inc. (INO) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 17:08 ESTNewsInovio Pharmaceuticals GAAP EPS of -$0.16 misses by $0.02, revenue of $0.11M misses by $0.17MN/A
2023-05-10 04:00 ESTNewsInovio Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-26 18:55 ESTNewsInovio's respiratory disorder therapy on way to get orphan drug status in EUN/A
2023-04-17 22:45 ESTNewsInovio gains on Phase 1 data for Ebola booster shotN/A
2023-04-04 16:10 ESTNewsInovio: Adrift At A Bargain Price But No Near-Term CatalystN/A
2023-03-14 06:00 ESTNewsInovio Pharmaceuticals, Inc. (INO) Oppenheimer 33rd Annual Healthcare Conference (Transcript)N/A
2023-03-02 17:57 ESTNewsInovio stock rises amid mixed trial results for cervical lesions drug; Q4 clinical updatesN/A
2023-03-02 03:13 ESTNewsInovio Pharmaceuticals GAAP EPS of -$1.17 misses by $0.06, revenue of $10.26M misses by $0.29MN/A
2023-03-02 03:13 ESTNewsInovio Pharmaceuticals, Inc. (INO) Q4 2022 Earnings Call TranscriptN/A
2023-02-28 21:36 ESTNewsInovio Pharmaceuticals FY 2022 Earnings PreviewN/A
2023-01-31 16:52 ESTNewsInovio in strategic reorganization; 11% headcount reductionN/A
2023-01-10 08:57 ESTNewsInovio: Hold For Future DNA Plasmid Therapy ProgressN/A
2022-11-17 22:53 ESTNewsInovio ends development of candidates for Lassa fever and Middle East Respiratory SyndromeN/A
2022-11-10 01:41 ESTNewsInovio Pharmaceuticals stock rises on Q3 profit beat, raised cash runway guidanceN/A
2022-11-09 07:26 ESTNewsInovio Pharmaceuticals GAAP EPS of -$0.15 beats by $0.15, revenue of $9.15MN/A
2022-11-09 07:25 ESTNewsInovio Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-09 07:25 ESTNewsInovio Pharmaceuticals, Inc. (INO) Q3 2022 Earnings Call TranscriptN/A
2022-11-07 20:30 ESTNewsInovio Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-10-28 02:30 ESTNewsInovio Pharmaceuticals stops development of COVID-19 booster shot candidateN/A
2022-10-24 23:11 ESTNewsInovio Pharmaceuticals: Catalysts On The HorizonN/A
2022-10-13 12:26 ESTNewsInovio reports positive phase 1/2 results for recurrent respiratory papillomatosis drugN/A
2022-09-27 12:45 ESTNewsInovio Pharmaceuticals: Long On Promise, Short On ResultsN/A
2022-09-12 19:28 ESTNewsInovio Pharmaceuticals, Inc. (INO) Presents at H.C. Wainwright 24th Annual Global Investment Conference (Transcript)N/A
2022-08-10 01:47 ESTNewsInovio Pharmaceuticals GAAP EPS of -$0.46 misses by $0.15, revenue of $0.78M beats by $0.26MN/A
2022-08-10 01:47 ESTNewsInovio beats on the top line but misses on the bottom; quarterly net loss widens 32%N/A
2022-08-10 01:46 ESTNewsInovio Pharmaceuticals, Inc. (INO) CEO Jacqueline Shea on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 03:59 ESTNewsInovio Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-19 18:54 ESTNewsInovio to cut workforce by 18% as part of corporate reorganizationN/A
2022-07-19 18:54 ESTNewsInovio Pharmaceuticals slotted at Sector Perform by RBC Capital in initial rating lookN/A
2022-07-19 04:14 ESTNewsInovio: After All These YearsN/A
2022-06-27 10:13 ESTNewsINOVIO appoints Dr. Michael Sumner as CMON/A
2022-06-08 20:43 ESTNewsInovio Pharmaceuticals, Inc. (INO) CEO Jacqui Shea Present at Jefferies 2022 Global Healthcare Conference (Transcript)N/A
2022-05-27 21:55 ESTNewsInovio announces positive survival results from trial testing glioblastoma treatmentN/A
2022-05-12 00:50 ESTNewsInovio downgraded at Oppenheimer as CEO departure adds uncertaintyN/A
2022-05-11 05:04 ESTNewsJacqueline Shea named new CEO of InovioN/A
2022-05-11 05:04 ESTNewsInovio Pharmaceuticals Non-GAAP EPS of -$0.36, revenue of $0.2MN/A
2022-05-11 05:04 ESTNewsInovio Pharmaceuticals falls 20% on Q1 misses, announcement of new CEON/A
2022-05-11 05:04 ESTNewsInovio Pharmaceuticals, Inc. (INO) on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 07:30 ESTNewsInovio Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-15 14:34 ESTNewsInovio: Long-Term Biotech To Own With Several Catalysts Expected In 2022N/A
2022-03-16 03:16 ESTNewsInovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim Presents at Oppenheimer's 32nd Annual Healthcare Conference (Transcript)N/A
2022-03-02 18:57 ESTNewsInovio Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-02 18:57 ESTNewsInovio COVID vaccine weaker vs Omicron in lab test; phase 3 trial enrollment pausedN/A
2022-03-02 02:32 ESTNewsInovio Pharmaceuticals GAAP EPS of -$1.45 misses by $0.19, revenue of $1.77M beats by $0.31MN/A
2022-03-02 02:32 ESTNewsInovio Pharmaceuticals results miss on the bottom line; shares down 9%N/A
2022-03-02 02:31 ESTNewsInovio Pharmaceuticals, Inc. (INO) CEO Dr. Joseph Kim on Q4 2021 Results - Earnings Call TranscriptN/A

About Inovio Pharmaceuticals, Inc (INO):

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon optimized plasmids that have ability to help break the immune system's tolerance of cancerous or infected cells and facilitate cross-strain protection against unmatched and matched pathogen variants. The company is involved in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, including head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, such as recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); Lassa fever; Zika virus; and the COVID-19 virus (coronavirus). Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company also has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800, which is currently in Phase I clinical testing for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquart

See Advanced Chart

General

  • Name Inovio Pharmaceuticals, Inc
  • Symbol INO
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 262
  • Last Split Factor1:4
  • Last Split Date2014-06-06
  • Fiscal Year EndDecember
  • IPO Date1998-02-12
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.inovio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 221.24
  • Price/Book (Most Recent Quarter) 4.76
  • Enterprise Value Revenue 245.85
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.59
  • Next Year EPS Estimate $0.25
  • Next Quarter EPS Estimate -$0.18
  • Operating Margin -1674%
  • Return on Assets -23%
  • Return on Equity -72%
  • Revenue 7.41 million
  • Earnings Per Share -$1.22
  • Revenue Per Share $0.05
  • Gross Profit -86834216
  • Quarterly Earnings Growth 1896.7%
View More

Highlights

  • Market Capitalization 2.15 billion
  • EBITDA -108041976
  • PE Ratio -1.54
  • Analyst Target Price $16
  • Book Value Per Share $2.47
View More

Share Statistics

  • Shares Outstanding 207.63 million
  • Shares Float 204.08 million
  • % Held by Insiders 217%
  • % Held by Institutions 36.49%
  • Shares Short 50.23 million
  • Shares Short Prior Month 43.09 million
  • Short Ratio 2.19
  • Short % of Float 25%
  • Short % of Shares Outstanding 24%
View More

Technicals

  • Beta 0.97
  • 52 Week High $33.79
  • 52 Week Low $6.5
  • 50 Day Moving Average 12.08
  • 200 Day Moving Average 11.47
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Inovio Pharmaceuticals, Inc (INO) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Inovio Pharmaceuticals, Inc (INO) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.11-$0.2250.85%
2020-09-302020-11-09$N/A$0.11-$0.19158.26%
2020-06-302020-08-10$N/A-$0.83-$0.17-391.71%
2020-03-312020-05-11$1.33 million-$0.26-$0.23-15.56%
2019-12-312020-03-12$279488-$0.38-$0.24-59.26%
2019-09-302019-11-12$866863-$0.23-$0.257.37%
2019-06-302019-08-08$135673-$0.30-$0.28-6.04%
2019-03-312019-05-09$2.83 million-$0.30-$0.26-15.38%
2018-12-312019-03-12$2.5 million-$0.34-$0.29-15.65%
2018-09-302018-11-08$2 million-$0.27-$0.3113.46%
2018-06-302018-08-07$24.45 million-$0.07-$0.2773.58%
2018-03-312018-05-09$1.53 million-$0.36-$0.08-350%
2017-12-312018-03-14$8.79 million-$0.23-$0.3022.48%
2017-09-302017-11-08$2.65 million-$0.39-$0.26-52.94%
2017-06-302017-08-08$20.41 million-$0.13-$0.1932.29%
2017-03-312017-05-10$10.38 million-$0.31-$0.310.8%
2016-12-312017-03-15$8.51 million-$0.35-$0.33-7.69%
2016-09-302016-11-09$12.54 million-$0.28-$0.27-4.48%
2016-06-302016-08-08$6.2 million-$0.26-$0.21-26.21%
2016-03-312016-05-09$8.11 million-$0.11-$0.2352.17%
2015-12-312016-03-14$5.94 million-$0.25-$0.21-21.95%
2015-09-302015-11-09$24.18 million$0.07$0.0475%
2015-06-302015-08-10$5.29 million-$0.09-$0.1330.77%
2015-03-312015-05-11$5.17 million-$0.17-$0.11-54.55%
2014-12-312015-03-16$2.46 million-$0.12-$0.10-20%
2014-09-302014-11-10$1.84 million-$0.12-$0.1414.29%
2014-06-302014-08-11$3.8 million-$0.18-$0.195.26%
2014-03-312014-05-12$2.36 million-$0.20-$0.16-25%
2013-12-312014-03-17$1.74 million-$0.28-$0.14-100%
2013-09-302013-11-12$9.49 million-$0.64-$0.10-540%
2013-06-302013-08-09$786000-$0.24-$0.14-71.43%
2013-03-312013-05-10$1.46 million-$0.24-$0.17-41.18%
2012-12-312013-03-18$1.14 million-$0.02-$0.1889.61%
2012-09-302012-11-07$855000-$0.20-$0.14-42.86%
2012-06-302012-08-09$436000-$0.12-$0.1729.41%
2012-03-312012-05-09$1.69 million-$0.24-$0.18-33.33%
2011-12-312012-03-15$1.63 million-$0.16-$0.2020%
2011-09-302011-11-07$2.64 million-$0.16-$0.13-23.08%
2011-06-302011-08-08$2.42 million-$0.08-$0.1957.89%
2011-03-312011-05-11$3.11 million-$0.08-$0.1546.67%
2010-12-312011-03-17$2.36 million-$0.28-$0.15-86.67%
2010-09-302010-11-15$1.28 million-$0.04-$0.1163.64%
2010-06-302010-08-16$1.13 million-$0.28-$0.08-250%
2010-03-312010-05-17$1.37 million-$0.08-$0.1855.56%
2009-12-312010-03-29$2.61 million-$0.28-$0.16-75%
2009-09-302009-11-16$3.65 million-$0.12-$0.2040%
2009-06-302009-08-19$2.49 million-$0.76-$0.24-216.67%
2009-03-312009-05-15$369000-$0.31
2008-12-312009-03-31$327000-$0.32-$0.28-14.29%
2008-09-302008-11-07$455000-$0.20-$0.3847.37%
2008-06-302008-08-07$663000-$0.36-$0.28-28.57%
2008-03-312008-05-09$653000-$0.28-$0.4436.36%
2007-12-312008-03-17$3.32 million-$0.08-$0.4782.98%
2007-09-302007-11-08$487000-$0.44-$0.39-12.82%
2007-06-302007-08-08$495000-$0.44-$0.40-10%
2007-03-312007-05-09$504000-$0.44-$0.37-18.92%
2006-12-312007-03-16$1.53 million-$0.56-$0.43-30.23%
2006-09-302006-11-08$576000-$0.44-$0.40-10%
2006-06-302006-08-08$663000-$0.40-$0.36-11.11%
2006-03-312006-05-09$698000-$0.36-$0.4418.18%
2005-12-312006-03-16$829000-$2.40-$0.64-275%
2005-09-302005-11-09$724000-$0.64-$0.8625.58%
2005-06-302005-08-09$2.95 million-$0.44-$0.9252.17%
2005-03-312005-05-10$962000-$0.88-$0.880%
2004-12-312005-03-15$543000-$0.84-$0.82-2.44%
2004-09-302004-11-15$455000-$0.80-$0.52-53.85%
2004-06-302004-08-09$100000-$0.13
2004-03-312004-05-15$69000-$0.40-$0.6437.5%
2003-12-312004-03-30$39000-$0.48-$0.480%
2003-09-302003-11-12$22000-$2.46
2003-06-302003-07-16$9000-$0.44
2003-03-312003-03-31$11000-$1.23

Inovio Pharmaceuticals, Inc (INO) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Inovio Pharmaceuticals, Inc (INO) Chart:

Inovio Pharmaceuticals, Inc (INO) News:

Below you will find a list of latest news for Inovio Pharmaceuticals, Inc (INO) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Inovio Pharmaceuticals, Inc (INO) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-150.50.82CALL3 99965.14TRUE-0.28-0.25
2026-05-1510.32CALL36 7790TRUE-0.08-0.2
2026-05-151.50.15CALL615 4969365.66FALSE00
2026-05-1520.04CALL143 4076361.36FALSE-0.01-0.2
2026-05-152.50.05CALL0 991181.58FALSE00
2026-05-1530.04CALL0 2191534.26FALSE00
2026-05-1540.05CALL0 3951000.09FALSE00
2026-05-1550.05CALL0 89887.93FALSE00
2026-05-1560.05CALL0 3230FALSE00
2026-05-1570.05CALL0 81347.55FALSE00
2026-05-150.50.03PUT0 2846.8FALSE00
2026-05-1510.02PUT2 91321.06FALSE0.020
2026-05-151.50.18PUT21 88248.29TRUE-0.05-0.22
2026-05-1520.6PUT0 222640.79TRUE00
2026-05-152.51.27PUT1 0842.72TRUE1.270
2026-05-1531.67PUT1 0723.42TRUE1.670
2026-05-1542.66PUT2 1850.76TRUE2.660
2026-05-1550PUT0 0673.41TRUE00
2026-05-1560PUT0 0747.68TRUE00
2026-05-1570PUT0 0808.99TRUE00
2026-05-220.50.8CALL0 17779.9TRUE00
2026-05-2210.45CALL0 13266.28TRUE00
2026-05-221.50.2CALL365 1870253.61FALSE00
2026-05-2220.07CALL79 539241.42FALSE-0.04-0.36
2026-05-222.50CALL0 0893.99FALSE00
2026-05-2230CALL0 1605.05FALSE00
2026-05-223.50.1CALL0 1628.96FALSE00
2026-05-220.50PUT0 2464.07FALSE00
2026-05-2210.05PUT0 99752.4FALSE00
2026-05-221.50.38PUT1 567352.62TRUE0.10.36
2026-05-2220.85PUT0 1140.41TRUE00
2026-05-222.50PUT0 0308.55TRUE00
2026-05-2230PUT0 0618.79TRUE00
2026-05-223.50PUT0 0555.27TRUE00
2026-05-290.50.89CALL0 16597.69TRUE00
2026-05-2910.5CALL0 13167.21TRUE00
2026-05-291.50.2CALL7 1355277.39FALSE-0.06-0.23
2026-05-2920.17CALL0 671302.37FALSE00
2026-05-292.50CALL0 0685.46FALSE00
2026-05-2930CALL0 0735.58FALSE00
2026-05-290.50.02PUT0 0356.12FALSE00
2026-05-2910.14PUT0 17219.14FALSE00
2026-05-291.50.05PUT0 2266.75TRUE00
2026-05-2920.7PUT0 10375.35TRUE00
2026-05-292.50PUT0 0360.51TRUE00
2026-05-2930PUT0 0388.1TRUE00
2026-06-050.50.97CALL12 14387.62TRUE-0.13-0.12
2026-06-0510.75CALL0 2348.61TRUE00
2026-06-051.50.3CALL9 2100233.2FALSE00
2026-06-0520.15CALL28 141218.3FALSE-0.02-0.12
2026-06-050.50.04PUT0 0299.89FALSE00
2026-06-0510PUT0 0486.47FALSE00
2026-06-051.50.4PUT0 50408.47TRUE00
2026-06-0520PUT0 0246.53TRUE00
2026-06-120.50.97CALL8 2340.55TRUE0.170.21
2026-06-1210.45CALL0 60TRUE00
2026-06-121.50.42CALL13 65280.94FALSE0.030.08
2026-06-1220.2CALL0 39330.85FALSE00
2026-06-120.50.05PUT0 0264.02FALSE00
2026-06-1210.19PUT0 400428.4FALSE00
2026-06-121.50PUT0 0309.73TRUE00
2026-06-1220.75PUT0 1309.61TRUE00
2026-06-180.50.99CALL0 1207.58TRUE00
2026-06-1810.6CALL0 528220.86TRUE00
2026-06-181.50.4CALL17 710245.21FALSE00
2026-06-1820.25CALL855 18783232.75FALSE00
2026-06-1830.1CALL1 244219.94FALSE-0.07-0.41
2026-06-1840.07CALL0 41221.71FALSE00
2026-06-1850CALL0 0941.38FALSE00
2026-06-180.50.03PUT0 1241.78FALSE00
2026-06-1810.12PUT15 237187.35FALSE-0.07-0.37
2026-06-181.50.43PUT6 12213.24TRUE-0.05-0.1
2026-06-1820PUT0 0241.91TRUE00
2026-06-1830PUT0 0249.64TRUE00
2026-06-1840PUT0 0281.03TRUE00
2026-06-1850PUT0 0247.61TRUE00
2026-06-260.51.05CALL0 3030TRUE00
2026-06-2610CALL0 0582.83TRUE00
2026-06-261.50.38CALL6 39211.53FALSE-0.07-0.16
2026-06-2620.25CALL26 1249210.89FALSE-0.04-0.14
2026-06-262.50CALL0 0316.98FALSE00
2026-06-260.50PUT0 00FALSE00
2026-06-2610PUT0 0356.15FALSE00
2026-06-261.50.33PUT0 1217.41TRUE00
2026-06-2620PUT0 0207.16TRUE00
2026-06-262.50PUT0 0224.08TRUE00
2026-08-210.50.98CALL0 17267.11TRUE00
2026-08-2110.55CALL0 33156.11TRUE00
2026-08-211.50.43CALL0 1288156.24FALSE00
2026-08-2120.27CALL33 883146.77FALSE-0.03-0.1
2026-08-2130.15CALL16 1933152.94FALSE-0.01-0.06
2026-08-2140CALL0 6262.48FALSE00
2026-08-2150.1CALL50 261180.16FALSE-0.05-0.33
2026-08-210.50.2PUT0 2330.05FALSE00
2026-08-2110.18PUT15 46143.87FALSE-0.07-0.28
2026-08-211.50.2PUT0 3146.81TRUE00
2026-08-2120PUT0 39157.6TRUE00
2026-08-2130PUT0 1135.12TRUE00
2026-08-2140PUT0 0176.45TRUE00
2026-08-2150PUT0 1199TRUE00
2026-09-180.50.95CALL1 17141.44TRUE-0.03-0.03
2026-09-1810.95CALL0 291137.52TRUE00
2026-09-181.50.5CALL0 16145.81FALSE00
2026-09-1820.33CALL0 746153.47FALSE00
2026-09-1830CALL0 22205.03FALSE00
2026-09-1840.2CALL0 79201.68FALSE00
2026-09-1850CALL0 1251.27FALSE00
2026-09-1870CALL0 15293.23FALSE00
2026-09-180.50PUT0 0292.68FALSE00
2026-09-1810PUT0 0157.65FALSE00
2026-09-181.50.5PUT0 41122.79TRUE00
2026-09-1820PUT0 77110.31TRUE00
2026-09-1830PUT0 2121.32TRUE00
2026-09-1840PUT0 0158.37TRUE00
2026-09-1850PUT0 1178.84TRUE00
2026-09-1870PUT0 0186.65TRUE00
2026-11-200.50CALL0 0283.99TRUE00
2026-11-2010CALL0 54138.07TRUE00
2026-11-201.50.6CALL0 19138.82FALSE00
2026-11-2020.43CALL0 53131.31FALSE00
2026-11-2030.34CALL0 250161.4FALSE00
2026-11-2040CALL0 0189.69FALSE00
2026-11-2050CALL0 0180.5FALSE00
2026-11-200.50.2PUT0 1321FALSE00
2026-11-2010.2PUT0 19995.03FALSE00
2026-11-201.50PUT0 0108.43TRUE00
2026-11-2020PUT0 0110.85TRUE00
2026-11-2030PUT0 1117.25TRUE00
2026-11-2040PUT0 0133.78TRUE00
2026-11-2050PUT0 0151.28TRUE00
2026-12-180.50CALL0 0195.44TRUE00
2026-12-1811.05CALL0 374128.57TRUE00
2026-12-181.50.5CALL12 569123.04FALSE00
2026-12-1820.38CALL20 7973123.56FALSE0.010.03
2026-12-1830.24CALL4 3091125.03FALSE-0.05-0.17
2026-12-1840.11CALL0 541188.47FALSE00
2026-12-1850.2CALL0 54191.8FALSE00
2026-12-1870.1CALL0 278301.43FALSE00
2026-12-180.50.2PUT1 2225.74FALSE0.030.18
2026-12-1810.35PUT0 1130.39FALSE00
2026-12-181.50.4PUT0 50126.58TRUE00
2026-12-1820PUT0 48133.19TRUE00
2026-12-1830PUT0 75110.71TRUE00
2026-12-1840PUT0 0126.46TRUE00
2026-12-1850PUT0 1143.15TRUE00
2026-12-1870PUT0 0151.43TRUE00
2027-01-150.51.09CALL1 8193.07TRUE1.090
2027-01-1510.75CALL7 359136.56TRUE00
2027-01-151.50.6CALL74 638139.93FALSE0.050.09
2027-01-1520.4CALL200 3783120.49FALSE00
2027-01-1530.25CALL851 1066119.79FALSE0.050.25
2027-01-1540.18CALL160 721122.65FALSE-0.09-0.33
2027-01-1550.15CALL121 1241128.36FALSE-0.01-0.06
2027-01-150.50.2PUT2 1213.08FALSE0.20
2027-01-1510PUT0 0155.3FALSE00
2027-01-151.50.57PUT0 12119.78TRUE00
2027-01-1520.59PUT0 1126.17TRUE00
2027-01-1530PUT0 0128.4TRUE00
2027-01-1540PUT0 0120.48TRUE00
2027-01-1554PUT0 1100.07TRUE00
2028-01-210.50CALL0 00TRUE00
2028-01-2111.05CALL0 20TRUE00
2028-01-211.50CALL0 00FALSE00
2028-01-2120.66CALL115 49112.3FALSE-0.14-0.18
2028-01-2130CALL0 087.92FALSE00
2028-01-2140CALL0 00FALSE00
2028-01-2150.3CALL1 20102.42FALSE0.050.2
2028-01-210.50PUT0 00FALSE00
2028-01-2110PUT0 00FALSE00
2028-01-211.50PUT0 00TRUE00
2028-01-2120PUT0 0213.5TRUE00
2028-01-2130PUT0 0135.83TRUE00
2028-01-2140PUT0 0115.88TRUE00
2028-01-2150PUT0 0124.75TRUE00

Latest INO Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST500$1.47
Jun 13, 2022 7:59 PM EST5$1.47
Jun 13, 2022 7:59 PM EST100$1.465
Jun 13, 2022 7:59 PM EST500$1.47
Jun 13, 2022 7:59 PM EST100$1.47

Inovio Pharmaceuticals, Inc (INO) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000043/0001055726-20-000043-index.htm
2018-06-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1055726/000000000018017637/0000000000-18-017637-index.htm
2020-02-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1055726/000000000020001261/0000000000-20-001261-index.htm
2020-03-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1055726/000000000020002492/0000000000-20-002492-index.htm
2020-04-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1055726/000000000020003215/0000000000-20-003215-index.htm
2020-05-01UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1055726/000000000020003771/0000000000-20-003771-index.htm
2019-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000021545719004059/0000215457-19-004059-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000081413319000020/0000814133-19-000020-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000081413320000032/0000814133-20-000032-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000083423720005356/0000834237-20-005356-index.htm
2018-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000021/0001055726-18-000021-index.htm
2018-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm
2018-04-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000023/0001055726-18-000023-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572618000026/0001055726-18-000026-index.htm
2018-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000027/0001055726-18-000027-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000028/0001055726-18-000028-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000029/0001055726-18-000029-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000030/0001055726-18-000030-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000031/0001055726-18-000031-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000032/0001055726-18-000032-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000033/0001055726-18-000033-index.htm
2018-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000034/0001055726-18-000034-index.htm
2018-07-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000037/0001055726-18-000037-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572618000040/0001055726-18-000040-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000042/0001055726-18-000042-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572618000045/0001055726-18-000045-index.htm
2018-11-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000047/0001055726-18-000047-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000048/0001055726-18-000048-index.htm
2018-12-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572618000049/0001055726-18-000049-index.htm
2019-01-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000003/0001055726-19-000003-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000004/0001055726-19-000004-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000006/0001055726-19-000006-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000007/0001055726-19-000007-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000008/0001055726-19-000008-index.htm
2019-03-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000009/0001055726-19-000009-index.htm
2019-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1055726/000105572619000012/0001055726-19-000012-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/0001055726-19-000013-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000014/0001055726-19-000014-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/0001055726-19-000015-index.htm
2019-03-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000017/0001055726-19-000017-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/0001055726-19-000018-index.htm
2019-03-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000021/0001055726-19-000021-index.htm
2019-03-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000022/0001055726-19-000022-index.htm
2019-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000023/0001055726-19-000023-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000024/0001055726-19-000024-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000025/0001055726-19-000025-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572619000029/0001055726-19-000029-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000030/0001055726-19-000030-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000031/0001055726-19-000031-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000032/0001055726-19-000032-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000033/0001055726-19-000033-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000034/0001055726-19-000034-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000035/0001055726-19-000035-index.htm
2019-05-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000036/0001055726-19-000036-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000037/0001055726-19-000037-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000038/0001055726-19-000038-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000039/0001055726-19-000039-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000040/0001055726-19-000040-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000041/0001055726-19-000041-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000042/0001055726-19-000042-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000044/0001055726-19-000044-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000047/0001055726-19-000047-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000049/0001055726-19-000049-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572619000052/0001055726-19-000052-index.htm
2019-08-15DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000054/0001055726-19-000054-index.htm
2019-09-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000056/0001055726-19-000056-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572619000058/0001055726-19-000058-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572619000059/0001055726-19-000059-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000001/0001055726-20-000001-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000002/0001055726-20-000002-index.htm
2020-01-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000003/0001055726-20-000003-index.htm
2020-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000004/0001055726-20-000004-index.htm
2020-01-24DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000005/0001055726-20-000005-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/0001055726-20-000006-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/0001055726-20-000007-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/0001055726-20-000008-index.htm
2020-03-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/0001055726-20-000009-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1055726/000105572620000012/0001055726-20-000012-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/0001055726-20-000013-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000014/0001055726-20-000014-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000015/0001055726-20-000015-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000016/0001055726-20-000016-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000017/0001055726-20-000017-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000018/0001055726-20-000018-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000019/0001055726-20-000019-index.htm
2020-03-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000022/0001055726-20-000022-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000024/0001055726-20-000024-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000025/0001055726-20-000025-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000026/0001055726-20-000026-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000027/0001055726-20-000027-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000028/0001055726-20-000028-index.htm
2020-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000029/0001055726-20-000029-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572620000032/0001055726-20-000032-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000033/0001055726-20-000033-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000034/0001055726-20-000034-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000035/0001055726-20-000035-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000036/0001055726-20-000036-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000037/0001055726-20-000037-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000038/0001055726-20-000038-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000039/0001055726-20-000039-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000040/0001055726-20-000040-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000042/0001055726-20-000042-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000043/0001055726-20-000043-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000044/0001055726-20-000044-index.htm
2020-07-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000045/0001055726-20-000045-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1055726/000105572620000048/0001055726-20-000048-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1055726/000105572620000049/0001055726-20-000049-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000110465920016487/0001104659-20-016487-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000114036120002954/0001140361-20-002954-index.htm
2018-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312518162187/0001193125-18-162187-index.htm
2018-05-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312518175305/0001193125-18-175305-index.htm
2018-05-25S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1055726/000119312518175375/0001193125-18-175375-index.htm
2018-06-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1055726/000119312518185845/0001193125-18-185845-index.htm
2018-06-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1055726/000119312518189390/0001193125-18-189390-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519001663/0001193125-19-001663-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519037998/0001193125-19-037998-index.htm
2019-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519045422/0001193125-19-045422-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519051968/0001193125-19-051968-index.htm
2019-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519071917/0001193125-19-071917-index.htm
2019-03-15S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1055726/000119312519076809/0001193125-19-076809-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519085283/0001193125-19-085283-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519144262/0001193125-19-144262-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519152325/0001193125-19-152325-index.htm
2019-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519158298/0001193125-19-158298-index.htm
2019-05-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1055726/000119312519162877/0001193125-19-162877-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519164685/0001193125-19-164685-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519194826/0001193125-19-194826-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312519214088/0001193125-19-214088-index.htm
2020-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520000651/0001193125-20-000651-index.htm
2020-01-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520008085/0001193125-20-008085-index.htm
2020-01-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1055726/000119312520021426/0001193125-20-021426-index.htm
2020-01-31S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1055726/000119312520021435/0001193125-20-021435-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520028310/0001193125-20-028310-index.htm
2020-02-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1055726/000119312520028334/0001193125-20-028334-index.htm
2020-02-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1055726/000119312520029793/0001193125-20-029793-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520065842/0001193125-20-065842-index.htm
2020-03-09424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1055726/000119312520065907/0001193125-20-065907-index.htm
2020-03-13S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1055726/000119312520072995/0001193125-20-072995-index.htm
2020-03-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1055726/000119312520088806/0001193125-20-088806-index.htm
2020-04-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1055726/000119312520098301/0001193125-20-098301-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520098305/0001193125-20-098305-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520099003/0001193125-20-099003-index.htm
2020-04-15DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1055726/000119312520108190/0001193125-20-108190-index.htm
2020-04-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1055726/000119312520119137/0001193125-20-119137-index.htm
2020-05-12424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1055726/000119312520140456/0001193125-20-140456-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520140512/0001193125-20-140512-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520145017/0001193125-20-145017-index.htm
2020-06-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520159486/0001193125-20-159486-index.htm
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520179128/0001193125-20-179128-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520239111/0001193125-20-239111-index.htm
2020-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520256781/0001193125-20-256781-index.htm
2020-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1055726/000119312520270257/0001193125-20-270257-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1055726/000121465920001194/0001214659-20-001194-index.htm
2018-06-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1055726/999999999518001464/9999999995-18-001464-index.htm
2020-02-13EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1055726/999999999520000352/9999999995-20-000352-index.htm
2020-03-31EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1055726/999999999520000654/9999999995-20-000654-index.htm

Inovio Pharmaceuticals, Inc (INO) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Inovio Pharmaceuticals, Inc (INO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 217%
Institutional Ownership: 3649%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-03-09PETER KIESCFOBuy25,000.00104,354.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000014/0001055726-19-000014-index.htm
2018-12-06AVTAR S DHILLONDirectorBuy25,000.002.0050,000.00106,002.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000049/0001055726-18-000049-index.htm
2019-06-03Jong Joseph KimChief Executive OfficerSell832,848.002.301,914,467.701,078,207.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm
2019-03-05Mark BagarazziChief Medical OfficerBuy27,567.00109,080.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000009/0001055726-19-000009-index.htm
2020-01-13Jong Joseph KimChief Executive OfficerBuy22,500.003.1169,975.001,100,707.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000002/0001055726-20-000002-index.htm
2019-05-31Jong Joseph KimChief Executive OfficerSell500,000.002.401,200,800.001,113,232.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm
2019-03-10PETER KIESCFOBuy20,433.00116,196.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000014/0001055726-19-000014-index.htm
2020-07-30Jong Joseph KimChief Executive OfficerSell100,000.0021.132,113,450.001,188,313.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000045/0001055726-20-000045-index.htm
2020-06-30PETER KIESCFOSell35,000.0026.50927,500.00119,290.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000043/0001055726-20-000043-index.htm
2020-07-15PETER KIESCFOSell35,000.0024.95873,208.00119,290.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000044/0001055726-20-000044-index.htm
2020-05-08Lota S. ZothDirectorBuy8,013.0012,103.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000028/0001055726-20-000028-index.htm
2020-03-05Jong Joseph KimChief Executive OfficerBuy120,100.001,220,807.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/0001055726-20-000008-index.htm
2019-05-11WENDY L YARNODirectorBuy8,170.0012,260.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000041/0001055726-19-000041-index.htm
2020-05-08Ann Calby MillerDirectorBuy8,013.0012,287.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000025/0001055726-20-000025-index.htm
2020-03-08Jong Joseph KimChief Executive OfficerBuy63,700.001,247,136.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000008/0001055726-20-000008-index.htm
2020-03-10Jong Joseph KimChief Executive OfficerBuy105,700.001,325,139.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000017/0001055726-20-000017-index.htm
2020-03-05PETER KIESCFOBuy27,567.00136,697.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/0001055726-20-000006-index.htm
2020-03-08PETER KIESCFOBuy21,467.00148,347.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000006/0001055726-20-000006-index.htm
2020-07-15PETER KIESCFOBuy35,000.002.4084,000.00154,290.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000044/0001055726-20-000044-index.htm
2018-05-12MORTON COLLINSDirectorBuy7,669.00159,960.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000030/0001055726-18-000030-index.htm
2019-05-16Jong Joseph KimChief Executive OfficerSell61,212.003.50214,242.001,613,232.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000042/0001055726-19-000042-index.htm
2020-03-10PETER KIESCFOBuy20,433.00161,356.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000014/0001055726-20-000014-index.htm
2019-12-05WENDY L YARNODirectorBuy4,090.0016,350.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000059/0001055726-19-000059-index.htm
2020-03-25Jacqueline Elizabeth SheaChief Operating OfficerBuy16,667.0016,667.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000019/0001055726-20-000019-index.htm
2019-05-15Jong Joseph KimChief Executive OfficerSell75,556.003.50264,446.001,674,444.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000042/0001055726-19-000042-index.htm
2019-05-11MORTON COLLINSDirectorBuy8,170.00168,130.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000037/0001055726-19-000037-index.htm
2019-05-31Jong Joseph KimChief Executive OfficerSell500,000.002.441,217,650.001,911,055.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm
2018-05-12ADEL MAHMOUDDirectorBuy7,669.0022,669.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000032/0001055726-18-000032-index.htm
2018-04-12Jong Joseph KimChief Executive OfficerSell103,750.005.14533,140.132,291,807.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm
2018-04-13Jong Joseph KimChief Executive OfficerSell107,500.005.06543,412.502,291,807.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm
2018-09-12Jong Joseph KimChief Executive OfficerSell49,060.005.37263,452.202,308,494.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000042/0001055726-18-000042-index.htm
2018-05-08Jong Joseph KimChief Executive OfficerBuy23,333.002,315,140.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000027/0001055726-18-000027-index.htm
2018-09-12Jong Joseph KimChief Executive OfficerBuy49,060.005.08249,224.802,357,554.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000042/0001055726-18-000042-index.htm
2018-04-12Jong Joseph KimChief Executive OfficerBuy103,750.002.40249,000.002,395,557.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm
2018-04-13Jong Joseph KimChief Executive OfficerBuy107,500.002.16232,200.002,399,307.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000022/0001055726-18-000022-index.htm
2019-05-21Jong Joseph KimChief Executive OfficerSell100,000.003.31331,000.002,411,055.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000044/0001055726-19-000044-index.htm
2019-03-05Jong Joseph KimChief Executive OfficerBuy120,100.002,428,594.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000007/0001055726-19-000007-index.htm
2020-05-08WENDY L YARNODirectorBuy8,013.0024,363.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000027/0001055726-20-000027-index.htm
2019-03-09Jong Joseph KimChief Executive OfficerBuy57,333.002,451,788.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/0001055726-19-000015-index.htm
2019-03-09Laurent HumeauChief Scientific OfficerBuy2,666.0024,867.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/0001055726-19-000018-index.htm
2019-03-10Jong Joseph KimChief Executive OfficerBuy105,700.002,541,159.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000015/0001055726-19-000015-index.htm
2019-03-10Laurent HumeauChief Scientific OfficerBuy2,812.0026,781.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000018/0001055726-19-000018-index.htm
2018-04-12SIMON X BENITODirectorSell3,750.005.2319,618.8827,798.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000021/0001055726-18-000021-index.htm
2018-04-12SIMON X BENITODirectorBuy3,750.003.5613,350.0031,548.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000021/0001055726-18-000021-index.htm
2018-05-12SIMON X BENITODirectorBuy7,669.0035,467.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000029/0001055726-18-000029-index.htm
2020-01-03Lota S. ZothDirectorBuy4,090.004,090.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000001/0001055726-20-000001-index.htm
2018-12-05WENDY L YARNODirectorBuy4,090.004,090.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000048/0001055726-18-000048-index.htm
2020-03-21Ann Calby MillerDirectorBuy4,274.004,274.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000018/0001055726-20-000018-index.htm
2019-05-11SIMON X BENITODirectorBuy8,170.0043,637.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000040/0001055726-19-000040-index.htm
2020-08-10Laurent HumeauChief Scientific OfficerSell19,467.0019.06371,004.0343,966.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000049/0001055726-20-000049-index.htm
2019-06-05Laurent HumeauChief Scientific OfficerBuy20,000.002.5050,000.0045,833.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000047/0001055726-19-000047-index.htm
2019-08-30Laurent HumeauChief Scientific OfficerBuy4,500.002.229,990.0050,333.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000056/0001055726-19-000056-index.htm
2020-05-08SIMON X BENITODirectorBuy8,013.0051,650.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000029/0001055726-20-000029-index.htm
2020-05-20SIMON X BENITODirectorSell8,750.0015.95139,594.0051,650.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000040/0001055726-20-000040-index.htm
2018-05-12Angel CabreraDirectorBuy7,669.0059,419.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000033/0001055726-18-000033-index.htm
2020-05-20SIMON X BENITODirectorBuy8,750.004.6040,250.0060,400.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000040/0001055726-20-000040-index.htm
2018-07-10PETER KIESCFOSell10,000.004.4544,500.0062,088.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000037/0001055726-18-000037-index.htm
2018-11-29PETER KIESCFOSell10,001.005.2852,805.2862,088.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000047/0001055726-18-000047-index.htm
2020-06-22Laurent HumeauChief Scientific OfficerSell19,467.0014.70286,164.9063,433.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000042/0001055726-20-000042-index.htm
2019-05-11Angel CabreraDirectorBuy8,170.0067,589.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000039/0001055726-19-000039-index.htm
2018-07-09PETER KIESCFOSell25,000.004.43110,750.0072,088.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000037/0001055726-18-000037-index.htm
2018-11-29PETER KIESCFOBuy10,001.002.0020,002.0072,089.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000047/0001055726-18-000047-index.htm
2020-05-08Angel CabreraDirectorBuy8,013.0075,602.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000024/0001055726-20-000024-index.htm
2018-04-16David B. WeinerDirectorSell9,000.004.9144,202.60758,956.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000023/0001055726-18-000023-index.htm
2018-05-12David B. WeinerDirectorBuy7,669.00766,625.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000034/0001055726-18-000034-index.htm
2019-03-05David B. WeinerDirectorBuy11,667.00778,292.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000008/0001055726-19-000008-index.htm
2020-03-05Laurent HumeauChief Scientific OfficerBuy27,567.0077,900.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/0001055726-20-000007-index.htm
2019-03-09David B. WeinerDirectorBuy5,333.00783,625.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/0001055726-19-000013-index.htm
2019-03-09David B. WeinerDirectorBuy10,000.00793,625.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/0001055726-19-000013-index.htm
2019-08-01David B. WeinerDirectorSell16,352.002.7244,477.44797,110.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000049/0001055726-19-000049-index.htm
2019-03-10David B. WeinerDirectorBuy11,667.00805,292.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000013/0001055726-19-000013-index.htm
2020-03-05David B. WeinerDirectorBuy11,667.00808,777.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/0001055726-20-000009-index.htm
2018-05-12AVTAR S DHILLONDirectorBuy7,669.0081,002.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000028/0001055726-18-000028-index.htm
2019-05-11David B. WeinerDirectorBuy8,170.00813,462.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000038/0001055726-19-000038-index.htm
2019-06-03Jong Joseph KimChief Executive OfficerSell296,705.002.31684,735.80816,527.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000046/0001055726-19-000046-index.htm
2020-03-09David B. WeinerDirectorSell3,500.0018.0063,000.00816,944.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/0001055726-20-000009-index.htm
2020-03-08David B. WeinerDirectorBuy11,667.00820,444.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000009/0001055726-20-000009-index.htm
2020-03-12David B. WeinerDirectorSell3,500.0011.1438,990.00821,610.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/0001055726-20-000013-index.htm
2020-03-10David B. WeinerDirectorSell3,500.009.3232,620.00825,110.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/0001055726-20-000013-index.htm
2020-05-11David B. WeinerDirectorSell2,404.0011.8428,463.36827,219.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000033/0001055726-20-000033-index.htm
2020-03-10David B. WeinerDirectorBuy11,666.00828,610.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000013/0001055726-20-000013-index.htm
2020-05-08David B. WeinerDirectorBuy8,013.00829,623.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000026/0001055726-20-000026-index.htm
2020-03-10Laurent HumeauChief Scientific OfficerBuy2,812.0083,873.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000015/0001055726-20-000015-index.htm
2020-03-08Laurent HumeauChief Scientific OfficerBuy19,900.0087,943.00https://www.sec.gov/Archives/edgar/data/1055726/000105572620000007/0001055726-20-000007-index.htm
2019-03-05PETER KIESCFOBuy27,567.0089,655.00https://www.sec.gov/Archives/edgar/data/1055726/000105572619000006/0001055726-19-000006-index.htm
2018-07-09PETER KIESCFOBuy15,000.004.2463,600.0097,088.00https://www.sec.gov/Archives/edgar/data/1055726/000105572618000037/0001055726-18-000037-index.htm